Get started
Roche Holding Ltd Dividend Right Cert.Roche Holding Ltd Dividend Right Cert.Roche Holding Ltd Dividend Right Cert.

Roche Holding Ltd Dividend Right Cert.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

RHO5 chart


Full chart

RHO5 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪234.32 B‬ EUR
Dividend yield (indicated)
3.54%
Price to earnings Ratio (TTM)
23.54
Basic EPS (TTM)
12.68 EUR
Net income (FY)
‪8.80 B‬ EUR
Revenue (FY)
‪64.34 B‬ EUR
Shares float
‪689.63 M‬
Beta (1Y)
1.29

Employees


Employees (FY)
‪103.25 K‬
Change (1Y)
−356 −0.34%
Revenue / Employee (1Y)
‪623.19 K‬ EUR
Net income / Employee (1Y)
‪85.27 K‬ EUR

About Roche Holding Ltd


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
ISIN
CH0012032048
FIGI
BBG00FGWJ8W5
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as RHO5.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RHO5 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

RHO5 highest yielding bonds


A3LRKK
Roche Kapitalmarkt AG 1.75% 15-SEP-2033 2023-15.09.33
Yield to maturity
—
Maturity date
Sep 15, 2033
CHGCY5317198
Roche Holdings, Inc. 2.076% 13-DEC-2031
Yield to maturity
—
Maturity date
Dec 13, 2031
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
—
Maturity date
Mar 8, 2034
A3K2RB
Roche Kapitalmarkt AG 0.75% 25-FEB-2031 2022-25.02.31 GUARANTEED REG S
Yield to maturity
—
Maturity date
Feb 25, 2031
CHGCY5766480
Roche Holdings, Inc. 4.79% 08-MAR-2029
Yield to maturity
—
Maturity date
Mar 8, 2029
A3K2JZ
Roche Kapitalmarkt AG 0.5% 25-FEB-2027 2022-25.02.27 GUARANTEED REG S
Yield to maturity
—
Maturity date
Feb 25, 2027
CHGCY5698942
Roche Holdings, Inc. 5.338% 13-NOV-2028
Yield to maturity
—
Maturity date
Nov 13, 2028
CHGCY4307677
Roche Holdings, Inc. 3.0% 10-NOV-2025
Yield to maturity
—
Maturity date
Nov 10, 2025
CHGCY5698943
Roche Holdings, Inc. 5.489% 13-NOV-2030
Yield to maturity
—
Maturity date
Nov 13, 2030
CHGCY5885610
Roche Holdings, Inc. 4.203% 09-SEP-2029
Yield to maturity
—
Maturity date
Sep 9, 2029
A3K88B
Roche Kapitalmarkt AG 1.5% 23-JUN-2026 2022-23.06.26 GUARANTEED
Yield to maturity
—
Maturity date
Jun 23, 2026

See all RHO5 bonds 

Sparks


Curated watchlists where RHO5 is featured.

See all sparks 

Frequently Asked Questions


The current price of RHO5 is 293.00 EUR — it has decreased by −0.53% in the past 24 hours. Watch Roche Holding Ltd Dividend Right Cert. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Roche Holding Ltd Dividend Right Cert. stocks are traded under the ticker RHO5.
RHO5 stock has risen by 5.28% compared to the previous week, the month change is a 7.72% rise, over the last year Roche Holding Ltd Dividend Right Cert. has showed a 9.94% increase.
We've gathered analysts' opinions on Roche Holding Ltd Dividend Right Cert. future price: according to them, RHO5 price has a max estimate of 467.70 EUR and a min estimate of 245.59 EUR. Watch RHO5 chart and read a more detailed Roche Holding Ltd Dividend Right Cert. stock forecast: see what analysts think of Roche Holding Ltd Dividend Right Cert. and suggest that you do with its stocks.
RHO5 reached its all-time high on May 6, 2025 with the price of 294.00 EUR, and its all-time low was 50.05 EUR and was reached on Mar 12, 2003. View more price dynamics on RHO5 chart.
See other stocks reaching their highest and lowest prices.
RHO5 stock is 0.73% volatile and has beta coefficient of 1.29. Track Roche Holding Ltd Dividend Right Cert. stock price on the chart and check out the list of the most volatile stocks — is Roche Holding Ltd Dividend Right Cert. there?
Today Roche Holding Ltd Dividend Right Cert. has the market capitalization of ‪232.62 B‬, it has increased by 0.34% over the last week.
Yes, you can track Roche Holding Ltd Dividend Right Cert. financials in yearly and quarterly reports right on TradingView.
Roche Holding Ltd Dividend Right Cert. is going to release the next earnings report on Jan 29, 2026. Keep track of upcoming events with our Earnings Calendar.
RHO5 earnings for the last half-year are 11.86 EUR per share, whereas the estimation was 11.19 EUR, resulting in a 5.98% surprise. The estimated earnings for the next half-year are 9.14 EUR per share. See more details about Roche Holding Ltd Dividend Right Cert. earnings.
Roche Holding Ltd Dividend Right Cert. revenue for the last half-year amounts to ‪34.08 B‬ EUR, despite the estimated figure of ‪33.04 B‬ EUR. In the next half-year revenue is expected to reach ‪33.51 B‬ EUR.
RHO5 net income for the last half-year is ‪7.93 B‬ EUR, while the previous report showed ‪2.15 B‬ EUR of net income which accounts for 269.20% change. Track more Roche Holding Ltd Dividend Right Cert. financial stats to get the full picture.
Yes, RHO5 dividends are paid annually. The last dividend per share was 10.17 EUR. As of today, Dividend Yield (TTM)% is 3.54%. Tracking Roche Holding Ltd Dividend Right Cert. dividends might help you take more informed decisions.
Roche Holding Ltd Dividend Right Cert. dividend yield was 3.80% in 2024, and payout ratio reached 93.40%. The year before the numbers were 3.93% and 66.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 7, 2025, the company has ‪103.25 K‬ employees. See our rating of the largest employees — is Roche Holding Ltd Dividend Right Cert. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Roche Holding Ltd Dividend Right Cert. EBITDA is ‪23.52 B‬ EUR, and current EBITDA margin is 35.81%. See more stats in Roche Holding Ltd Dividend Right Cert. financial statements.
Like other stocks, RHO5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Roche Holding Ltd Dividend Right Cert. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Roche Holding Ltd Dividend Right Cert. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Roche Holding Ltd Dividend Right Cert. stock shows the strong buy signal. See more of Roche Holding Ltd Dividend Right Cert. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.